Lv7
4160 积分 2023-02-17 加入
Navigating the switch from IVIG to FcRn inhibition in CIDP: Clinical insights
1个月前
已完结
OP0041 Treatment of primary Sjögren's disease by blocking FcRn: clinical and translational data from RHO, a phase 2 randomized, placebo controlled, double-blind, proof-of-concept study with efgartigimod
1个月前
已完结
Discovery, Synthesis, and Biological Evaluation of Novel Quinoline-Based PDE4 Inhibitors with Potent Anti-Chronic Obstructive Pulmonary Disease Activity
1个月前
已完结
PALI-2108, A COLON TARGETED PDE4B INHIBITOR, RAPIDLY RESTORES IMMUNE-EPITHELIAL BALANCE IN ULCERATIVE COLITIS THROUGHGUT-SELECTIVE LYMPHOCYTE DEPLETION
1个月前
已完结
S1331 Colonic Bioactivation and Potent TNFa Inhibition of PALI-2108 in Human ex-vivo Studies: A Promising PDE4 Inhibitor Prodrug for the Oral Treatment of Ulcerative Colitis
1个月前
已完结
METABOLITE MIMICRY REVEALS BUTYRATE ANALOG WITH SELECTIVE PROTECTIVE FUNCTIONS IN THE INTESTINAL MUCOSA
1个月前
已完结
MITOCHONDRIAL TURNOVER IS ELEVATED IN RESPONSE TO INTESTINAL INFLAMMATION AND IS AMENABLE TO THERAPUTIC TARGETING VIA UROLITHIN A
1个月前
已完结
PALI-2108, A COLON TARGETED PDE4B INHIBITOR, RAPIDLY RESTORES IMMUNE-EPITHELIAL BALANCE IN ULCERATIVE COLITIS THROUGHGUT-SELECTIVE LYMPHOCYTE DEPLETION
1个月前
已完结
A systematic review of novel Phosphodiesterase-4 inhibitors in the treatment of psoriasis
1个月前
已完结
Phosphodiesterase-4 Inhibitors in Chronic Obstructive Pulmonary Disease: Molecular Mechanisms, Current Therapeutics, and Future Perspectives
1个月前
已完结
皖公网安备34019202002308
